I now have everything needed for a full visual lesson. Let me build it.
𧬠Neoplasia - Your Complete Preclinical Lesson
Source: Robbins & Kumar Basic Pathology + Robbins, Cotran & Kumar Pathologic Basis of Disease
πΊοΈ Lesson Roadmap
1. What IS a neoplasm?
2. Nomenclature (how tumors are named)
3. Benign vs Malignant (the big distinction)
4. Hallmarks of Cancer (the 8 properties)
5. Metastasis - how cancer spreads
6. Grading vs Staging
1. What is a Neoplasm?
A neoplasm (Greek: neos = new, plasma = formation) is an abnormal mass of tissue whose growth exceeds and is uncoordinated with that of normal tissues, and persists even after the stimulus is removed.
Key facts from Robbins:
- Cancer is a genetic disorder caused by DNA mutations (inherited, spontaneous, or due to mutagens)
- Mutations are heritable - passed to daughter cells (Darwinian selection)
- Tumors start from one cell (clonal origin) - that cell gained a growth/survival advantage
- Over time, the tumor undergoes clonal evolution - subclones with more aggressive traits emerge (tumor progression)
Think of it like this: one mutant cell "wins" a survival competition, then its descendants keep mutating and evolving into a more aggressive tumor.
2. Nomenclature (How Tumors Are Named)
The naming system follows two rules:
- Tissue of origin (where it comes from)
- Benign vs Malignant (what it does)
| Tissue of Origin | Benign Tumor | Malignant Tumor |
|---|
| Epithelium (glands) | Adenoma | Adenocarcinoma |
| Epithelium (squamous) | Squamous papilloma | Squamous cell carcinoma |
| Connective tissue / fat | Lipoma | Liposarcoma |
| Smooth muscle | Leiomyoma | Leiomyosarcoma |
| Blood vessels | Hemangioma | Angiosarcoma |
| Bone | Osteoma | Osteosarcoma |
| Cartilage | Chondroma | Chondrosarcoma |
| Melanocytes | Nevus (mole) | Melanoma* |
| Lymphoid tissue | - | Lymphoma* |
| Germ cells (ovary/testis) | Mature teratoma | Immature teratoma / Seminoma* |
*Exception: some malignant tumors have non-standard "benign-sounding" names - memorize these!
Quick rule:
-oma = usually benign (adenoma, lipoma, fibroma)
Carcinoma = malignant tumor of epithelial origin
Sarcoma = malignant tumor of mesenchymal (connective tissue) origin
3. Benign vs Malignant - The Big 4 Differences
| Feature | Benign | Malignant |
|---|
| Differentiation | Well-differentiated (looks like normal cells) | Poorly differentiated / anaplastic |
| Local invasion | Does NOT invade (pushes, doesn't infiltrate) | Invades and destroys surrounding tissue |
| Metastasis | NEVER metastasizes | Can metastasize (hallmark of malignancy) |
| Growth rate | Slow (but exceptions exist) | Usually faster (variable) |
Anaplasia - Features of Malignant Cells
When a tumor is anaplastic (poorly differentiated), look for:
- Pleomorphism - cells and nuclei vary greatly in size/shape
- Hyperchromatism - dark-staining nuclei (excess DNA)
- High N:C ratio - nucleus takes up most of the cell
- Prominent nucleoli - big, irregular nucleoli
- Abnormal mitoses - tripolar, ring-shaped mitotic figures
- Tumor giant cells - bizarre, large cells (sometimes multinucleated)
4. The 8 Hallmarks of Cancer
This is the most important conceptual framework in oncology. All cancers acquire these properties:
From Hanahan D, Weinberg RA: Hallmarks of Cancer: The Next Generation. Cell 2011.
Let's break each one down:
| # | Hallmark | Plain English | Key Examples |
|---|
| 1 | Sustaining proliferative signaling | Cancer makes its own "grow" signals | RAS oncogene mutation; EGFR overexpression |
| 2 | Evading growth suppressors | Cancer ignores "stop growing" signals | TP53 mutation; RB gene loss |
| 3 | Enabling replicative immortality | Cancer cells never stop dividing | Telomerase reactivation |
| 4 | Resisting cell death | Cancer blocks apoptosis | BCL-2 overexpression (e.g. follicular lymphoma) |
| 5 | Inducing angiogenesis | Cancer grows new blood vessels to feed itself | VEGF upregulation |
| 6 | Activating invasion and metastasis | Cancer spreads to other organs | E-cadherin loss; MMP secretion |
| 7 | Deregulating cellular energetics | Cancer prefers glycolysis even with O2 (Warburg effect) | Basis for FDG-PET imaging |
| 8 | Avoiding immune destruction | Cancer hides from immune cells | PD-L1 expression; basis for checkpoint inhibitor therapy |
Enabling factors (help acquire hallmarks faster):
- Genomic instability - accumulate mutations more rapidly
- Tumor-promoting inflammation - inflammatory microenvironment drives tumor growth
5. Metastasis - How Cancer Spreads
Metastasis = establishment of tumor at a site discontinuous from the primary tumor. It is the single most important feature distinguishing malignant from benign.
From Robbins & Kumar Basic Pathology
The Metastatic Cascade (Step-by-Step):
Primary Tumor
β
1. LOOSENING - E-cadherin expression β β cells detach from each other
β
2. INVASION - MMPs degrade basement membrane & ECM
β
3. INTRAVASATION - Enter blood vessel or lymphatic
β
4. SURVIVAL IN CIRCULATION - Form emboli with platelets (protection from immune attack)
β
5. EXTRAVASATION - Attach to distant vessel endothelium, exit vessel
β
6. MICROMETASTASIS β MACROMETASTASIS - Angiogenesis + growth at new site
Routes of Spread:
| Route | What Spreads This Way | Classic Example |
|---|
| Lymphatic | Most carcinomas (epithelial) | Breast cancer β axillary lymph nodes |
| Hematogenous | Most sarcomas (also carcinomas late) | Renal cell carcinoma β lungs/bone |
| Seeding (transcoelomic) | Ovarian cancer, GI cancer | Ovarian cancer β peritoneum |
| Perineural | Prostate, pancreatic cancer | Prostatic adenocarcinoma |
Common Sites of Metastasis (to memorize):
| Primary Cancer | Favorite Mets Sites |
|---|
| Lung | Brain, bone, adrenal, liver |
| Breast | Bone (osteolytic), lung, liver, brain |
| Prostate | Bone (osteoblastic) |
| Colon | Liver (portal drainage) |
| Kidney | Lung, bone |
6. Grading vs Staging
Students mix these up constantly - here's the difference:
| Grading | Staging |
|---|
| What it measures | How abnormal cells LOOK (differentiation) | How far cancer has SPREAD |
| Determined by | Pathologist (microscope) | Clinician (imaging, surgery) |
| Scale | Grade 1 (well-diff) β Grade 3-4 (poorly diff/anaplastic) | Stage I (localized) β Stage IV (distant mets) |
| System | Histologic grade | TNM system (Tumor, Nodes, Metastasis) |
| Predicts | Aggressiveness of tumor cells | Extent of disease / prognosis |
TNM breakdown:
- T (1-4) = Size/extent of primary tumor
- N (0-3) = Regional lymph node involvement
- M (0 or 1) = Distant metastasis present or absent
Rule of thumb: Grade tells you about the tumor's personality (aggressive or lazy). Stage tells you about its geography (how far it's gone).
Quick Exam Memory Aids
| Mnemonic | What It Covers |
|---|
| "Carcinomas via Lymphatics, Sarcomas via blood" | Routes of spread |
| "Benign = Bland, Malignant = Mean" | Histologic features |
| "Grade = Microscope, Stage = Map" | Grading vs staging |
| BCL2 blocks apoptosis | Follicular lymphoma mechanism |
| Warburg effect = PET scan works | Metabolic hallmark |
What's Next?
Now that you have the foundations, the natural next chapters to build on this are:
- Oncogenes & Tumor Suppressor Genes (RAS, MYC, RB, TP53 in detail)
- Carcinogens (chemical, radiation, viral - HPV, EBV, HBV)
- Paraneoplastic Syndromes (remote effects of cancer)
- Tumor Immunology (checkpoint inhibitors, CAR-T)
Want me to go deep on any of these? Or run you through practice questions on what we just covered?